메드페이스 홀딩스, Inc.
US ˙ NasdaqGS ˙ US58506Q1094

SecurityMEDP / Medpace Holdings, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership305 shares
Latest Disclosed Value $ 95,727
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 0.97% decrease in ownership of MEDP / Medpace Holdings, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 305 shares of Medpace Holdings, Inc. (US:MEDP) valued at $95,727 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 308 shares of Medpace Holdings, Inc.. This represents a change in shares of -0.97% during the quarter. The current value of the position is $139,900 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Medpace Holdings EC US58506Q1094 305 -3 -0.97 96 2.15 1.0639
2025-05-29 2025-03-31 NP Medpace Holdings EC US58506Q1094 308 -9 -2.84 94 -11.43 0.9969
2025-03-03 2024-12-31 NP Medpace Holdings EC US58506Q1094 317 -11 -3.35 105 -3.67 1.0558
2024-11-29 2024-09-30 NP Medpace Holdings EC US58506Q1094 328 -12 -3.53 109 -22.14 0.9917
2024-08-29 2024-06-30 NP Medpace Holdings EC US58506Q1094 340 -22 -6.08 140 -4.11 1.2766
2024-05-30 2024-03-31 NP Medpace Holdings EC US58506Q1094 362 -95 -20.79 146 4.29 1.2407
2024-02-29 2023-12-31 NP Medpace Holdings EC US58506Q1094 457 -79 -14.74 140 8.53 1.1481
2023-11-29 2023-09-30 NP Medpace Holdings EC US58506Q1094 536 -80 -12.99 130 -12.24 1.1237
2023-08-28 2023-06-30 NP Medpace Holdings EC US58506Q1094 616 68 12.41 148 42.72 1.1675
2023-05-30 2023-03-31 NP Medpace Holdings EC US58506Q1094 548 -469 -46.12 103 -52.31 0.7805
2023-02-28 2022-12-31 NP Medpace Holdings EC US58506Q1094 1,017 -46 -4.33 216 29.34 1.3064
2022-11-29 2022-09-30 NP Medpace Holdings EC US58506Q1094 1,063 -79 -6.92 167 -1.76 1.1659
2022-08-29 2022-06-30 NP Medpace Holdings EC US58506Q1094 1,142 -95 -7.68 171 -15.84 1.1726
2022-05-26 2022-03-31 NP Medpace Holdings EC US58506Q1094 1,237 -33 -2.60 202 -26.81 1.1958
2022-02-28 2021-12-31 NP Medpace Holdings EC US58506Q1094 1,270 6 0.47 276 15.48 1.2214
2021-11-29 2021-09-30 NP Medpace Holdings EC US58506Q1094 1,264 -69 -5.18 239 1.70 1.0057
2021-08-27 2021-06-30 NP Medpace Holdings EC US58506Q1094 1,333 -127 -8.70 235 -1.67 0.9861
2021-05-27 2021-03-31 NP Medpace Holdings EC US58506Q1094 1,460 -253 -14.77 240 0.42 1.0778
2021-03-01 2020-12-31 NP Medpace Holdings EC US58506Q1094 1,713 1,713 238 0.9711
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.